China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $0.18 on Monday. The firm has a 50 day simple moving average of $0.22 and a 200-day simple moving average of $0.23. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a 1-year low of $0.17 and a 1-year high of $0.69.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.